CRIMALDDI: platform technologies and novel anti-malarial drug targets

被引：0
|
作者：
Henri Vial
Donatella Taramelli
Ian C Boulton
Steve A Ward
Christian Doerig
Kelly Chibale
机构：
[1] Université Montpellier 2,Centre National de la Recherche Scientifique, UMR 5235
[2] Università di Milano,Dipartmento di Scienze Farmacologiche e Biomolecolari
[3] TropMed Pharma Consulting Ltd,Department of Microbiology
[4] Liverpool School of Tropical Medicine,Department of Chemistry
[5] School of Biomedical Sciences,undefined
[6] Monash University,undefined
[7] University of Cape Town,undefined
来源：
Malaria Journal | / 12卷
关键词：
CRIMALDDI; Malaria; Drug discovery; Research agenda; Novel targets; Enabling technologies; Prioritization;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
The Coordination, Rationalization, and Integration of antiMALarial drug Discovery & Development Initiatives (CRIMALDDI) Consortium, funded by the EU Framework Seven Programme, has attempted, through a series of interactive and facilitated workshops, to develop priorities for research to expedite the discovery of new anti-malarials. This paper outlines the recommendations for the development of enabling technologies and the identification of novel targets.
引用
收藏
相关论文
共 50 条
  • [21] Synthesis and biological evaluation of a novel anti-malarial lead
    Hammond, Nicholas L.
    Choi, Seoung-ryoung
    Carvalho, Paulo
    Liu, Hua
    Khan, Shabana
    Avery, Mitchell A.
    MEDICINAL CHEMISTRY RESEARCH, 2011, 20 (04) : 401 - 407
  • [22] Synthesis and biological evaluation of a novel anti-malarial lead
    Nicholas L. Hammond
    Seoung-ryoung Choi
    Paulo Carvalho
    Hua Liu
    Shabana Khan
    Mitchell A. Avery
    Medicinal Chemistry Research, 2011, 20 : 401 - 407
  • [23] Structural Characterization and Thermal Properties of the Anti-malarial Drug: Lumefantrine
    Pansuriya, Pramod B.
    Maguire, Glenn E. M.
    Friedrich, Holger B.
    SOUTH AFRICAN JOURNAL OF CHEMISTRY-SUID-AFRIKAANSE TYDSKRIF VIR CHEMIE, 2019, 72 : 253 - +
  • [24] Anti-malarial effect of semi-synthetic drug amitozyn
    Sergey O. Tcherniuk
    Olga Chesnokova
    Irina V. Oleinikov
    Anatoly I. Potopalsky
    Andrew V. Oleinikov
    Malaria Journal, 14
  • [25] Setting Up an NGS Sequencing Platform and Monitoring Molecular Markers of Anti-Malarial Drug Resistance in Djibouti
    Papa Mze, Nasserdine
    Arreh, Houssein Yonis
    Moussa, Rahma Abdi
    Elmi, Mahdi Bachir
    Waiss, Mohamed Ahmed
    Abdi, Mohamed Migane
    Robleh, Hassan Ibrahim
    Guelleh, Samatar Kayad
    Abdi, Abdoul-ilah Ahmed
    Bogreau, Herve
    Basco, Leonardo K.
    Khaireh, Bouh Abdi
    BIOLOGY-BASEL, 2024, 13 (11):
  • [26] Apical Membrane Antigen 1 as an Anti-Malarial Drug Target
    MacRaild, Christopher A.
    Anders, Robin F.
    Foley, Michael
    Norton, Raymond S.
    CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2011, 11 (16) : 2039 - 2047
  • [27] Anti-malarial Drug Design by Targeting Apicoplasts: New Perspectives
    Mukherjee, Avinaba
    Sadhukhan, Gobinda Chandra
    JOURNAL OF PHARMACOPUNCTURE, 2016, 19 (01) : 7 - 15
  • [28] Targeting Host Factors to Circumvent Anti-Malarial Drug Resistance
    Prudencio, Miguel
    Mota, Maria M.
    CURRENT PHARMACEUTICAL DESIGN, 2013, 19 (02) : 290 - 299
  • [29] Anti-malarial effect of semi-synthetic drug amitozyn
    Tcherniuk, Sergey O.
    Chesnokova, Olga
    Oleinikov, Irina V.
    Potopalsky, Anatoly I.
    Oleinikov, Andrew V.
    MALARIA JOURNAL, 2015, 14
  • [30] Recent progress in the development of anti-malarial quinolones
    Beteck, Richard M.
    Smit, Frans J.
    Haynes, Richard K.
    N'Da, David D.
    MALARIA JOURNAL, 2014, 13
12345